A Study of Aflibercept Versus Placebo With FOLFIRI in Asian Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy
by on Friday, August 10th, 2012 | No Comments
Condition: Colorectal Cancer Metastatic
Interventions: Drug: Aflibercept AVE0005; Drug: Placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Active, not recruiting – verified August 2012
Read the rest here: A Study of Aflibercept Versus Placebo With FOLFIRI in Asian Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy